Výsledky vyhledávání - "Catia Duarte"

Do Supply Chain Management Practices Influence Firm Performance?

Autor: Maria R. A. Moreira, Graça Maciel Amaro, Paulo Sousa, Catia Duarte Silva

Publikováno v: International Journal of Information Systems and Supply Chain Management. 13:1-22

Firms recognize that an assertive SCM could lead to an important competitive advantage in the business world. The purpose of this study is to capture the effect of supply chain management practices in the performance of firms, through a meta-analysis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::05006774614231445b4e1f6b23bf5f19
https://doi.org/10.4018/ijisscm.2020070101

Zobrazit plný text záznamu

Treating-to-target in rheumatology: Theory and practice

Autor: Ricardo Jorge De Oliveira Ferreira, Eduardo José Ferreira Santos, Catia Duarte, Jose Da Silva

Publikováno v: Best practiceresearch. Clinical rheumatology. 36(1)

Despite its inclusion in current treatment recommendations, adherence to the treat-to-target strategy (T2T) is still poor. Among the issues are the definition(s) of target, especially the caveats of the patient global assessment (PGA), included in al

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf0bf0fdeaa627bd5a55d19cd4e69b4e
https://pubmed.ncbi.nlm.nih.gov/34980566

Zobrazit plný text záznamu

Safety of Vaccination against SARS-CoV-2 in People with Rheumatic and Musculoskeletal Diseases: Results from the EULAR Coronavirus Vaccine (COVAX) Physician-Reported Registry

Publikováno v: Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 2022, 81 (5), pp.695--709. ⟨10.1136/annrheumdis-2021-221490⟩
Lawson-Tovey, S, Hyrich, K, Kearsley-Fleet, L & et al. 2022, ' Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry ', Annals of the rheumatic diseases, vol. 81, pp. 695-709 . https://doi.org/10.1136/annrheumdis-2021-221490
Annals of the rheumatic diseases, Vol. 81, no.5, p. 695-709 (2022)

ObjectivesTo describe the safety of vaccines against SARS-CoV-2 in people with inflammatory/autoimmune rheumatic and musculoskeletal disease (I-RMD).MethodsPhysician-reported registry of I-RMD and non-inflammatory RMD (NI-RMDs) patients vaccinated ag

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0177d6472d0b9b7583c3beb732f28398
https://hal.sorbonne-universite.fr/hal-03896047

Zobrazit plný text záznamu

Portuguese Recommendations for the use of biological therapies in patients with rheumatoid arthritis- 2016 update

Autor: Catia Duarte, Joana Sousa-Neves, Ana Águeda, Pedro Ribeiro, Alexandra Daniel, Gisela Eugénio, Sofia Serra, Filipe Araújo, Anabela Barcelos, Barcelos Filipe, Miguel Bernardes, Helena Canhão, Marcos Cerqueira, Susana Capela, Ana Cordeiro, Flavio Costa, Lucia Costa, Margarida Cruz, Luis Cunha Miranda, Catarina Duarte, Sandra Falcao, Daniela Faria, Ricardo Figueira, João Pedro Freitas, Maria João Gonçalves, João Madruga Dias, José Melo Gomes, Ana Filipa Mourão, Adriano Neto, Filipa Oliveira Ramos, Sofia Pimenta, Patricia Pinto, Joaquim Polido-Pereira, Cristina Ponte, João Ramos, Ana Rodrigues, Helena Santos, Maria José Santos, Alexandre Sepriano, Candida Silva, José Tavares Costa, Filipa Teixeira, Vitor Teixeira, Paula Valente, Elsa Vieira-Sousa, Rita Barros, Pedro Abreu, João Eurico Fonseca

Publikováno v: Acta Reumatológica Portuguesa, Vol 2017, Iss 2, Pp 112-126 (2017)
Universidade Nova de Lisboa
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP

OBJECTIVE: To update the recommendations for the treatment of Rheumatoid Arthritis (RA) with biological therapies, endorsed by the Portuguese Society of Rheumatology (SPR). METHODS: These treatment recommendations were formulated by Portuguese rheuma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::25460c22d6a006a34a0fd2d7c68dd0a2
http://www.actareumatologica.com/files/article/1173_portuguese_recommendations_for_the_use_of_biological_therapies_in_patients_with_rheumatoid_arthritis_2016_update_file.pdf

Zobrazit plný text záznamu

List of Contributors

Autor: Joseph M. Ahearn, Olga Amengual, Zahir Amoura, Cynthia Aranow, John P. Atkinson, Tatsuya Atsumi, Ingrid Avalos, Dimitrios Balomenos, Jacques Banchereau, George Bertsias, Markus Böhm, Dimitrios T. Boumpas, D. Ware Branch, Hermine I. Brunner, Jill P. Buyon, Livia Casciola-Rosen, Ricard Cervera, George Chamilos, Edward K.L. Chan, Robert M. Clancy, Christine A. Clark, Nathalie Costedoat-Chalumeau, Maura Couto, José C. Crispín, Mary K. Crow, Michael J. Day, Betty Diamond, Iris Dotan, Roland M. du Bois, Yong Du, Catia Duarte, Yun Deng, Jan P. Dutz, Olga Dvorkina, Thomas Ernandez, Gerard Espinosa, A. Darise Farris, Michelle M.A. Fernando, Barri J. Fessler, Aryeh Fischer, Deborah M. Friedman, Marvin J. Fritzler, Richard Furie, Gary S. Gilkeson, Ellen M. Ginzler, John G. Hanly, Evelyn V. Hess, Gary S. Hoffman, Diane Horowitz, Luis Ines, Yiannis Ioannou, Judith A. James, Caroline A. Jefferies, Kenneth C. Kalunian, Mariana J. Kaplan, Grainne Kearns, Mary Keogan, Cristián Vera Kellet, Munther A. Khamashta, Takao Koike, Dwight H. Kono, Steven A. Krilis, Annegret Kuhn, Vasileios C. Kyttaris, Robert G. Lahita, Carl A. Laskin, Gaëlle Leroux, Yi Li, Matthew H. Liang, Chau-Ching Liu, Thomas Luger, Ian R. Mackay, Meggan Mackay, Kathleen Maksimowicz-McKinnon, Mark J. Mamula, Susan Manzi, Galina Marder, Ahmad K. Mashmoushi, T.N. Mayadas, Lloyd Mayer, Terry K. Means, Joan T. Merrill, Kristina E. Milan, Rina Mina, Chandra Mohan, Anne-Barbara Mongey, Seetha U. Monrad, Johannes C. Nossent, Jim C. Oates, Gerlinde Obermoser, Karolina Palucka, Eva D. Papadimitraki, Virginia Pascual, Andras Perl, Jean-Charles Piette, Shiv Pillai, Westley H. Reeves, Bruce C. Richardson, Anthony Rosen, Brad H. Rovin, Minoru Satoh, Peter Schur, Karen A. Spitzer, C. Michael Stein, Isaac E. Stillman, Tom J.G. Swaak, Kendra N. Taylor, Argyrios N. Theofilopoulos, Betty P. Tsao, George Tsokos, Hideki Ueno, Aziz M. Uluğ, Evan S. Vista, Bruce T. Volpe, Tim J. Vyse, Mark H. Wener, Victoria P. Werth, Yuan Xu, Lijun Yang, C. Yung Yu, Raymond L. Yung, Dun Zhou, Haoyang Zhuang

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1c686a823a4cc2394dfab4688c8d74f7
https://doi.org/10.1016/b978-0-12-374994-9.10064-6

Zobrazit plný text záznamu

Oral contraceptives and systemic lupus erythematosus: what should we advise to our patients?

Autor: Catia Duarte, Inês, L.

Publikováno v: Europe PubMed Central
Scopus-Elsevier

Oral contraceptives (OC) are the contraceptive method of choice for the majority of Western world women. Decision on giving OC to patients with Systemic Lupus Erythematosus (SLE) puts special issues and concerns. In fact, OC have been evocated as eti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2afbda5ef29824f6332e3d4ed0151f30
https://hdl.handle.net/10400.4/821

Zobrazit plný text záznamu

Perfil de risco cardiovascular numa população portuguesa de doentes com LES

Autor: Catia Duarte, Couto M, Vaz C, Inês L, Malcata A

Publikováno v: Europe PubMed Central
CIÊNCIAVITAE

Systemic Lupus Erythematosus is associated with an increased risk of atherosclerosis and cardiovascular events, as compared to the general population. Objective: To evaluate the prevalence of «traditional» cardiovascular risk factors in Portuguese

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2dedac6fa6102bdac481ffb80c75b063
https://hdl.handle.net/10400.4/630

Zobrazit plný text záznamu

Budd-Chiari syndrome and severe thrombocytopenia in a patient with Systemic Lupus Erythematosus and Secondary Antiphospholipid Syndrome

Autor: Catia Duarte, Couto M, Inês L, Malcata A

Publikováno v: CIÊNCIAVITAE
Europe PubMed Central

Systemic Lupus Erythematosus (SLE) is a rheumatic autoimmune disease characterized by multisystemic involvement with a variable prognosis. The association with Antiphospholipid Syndrome (APS) occurs in about 36% of the patients, raising additional pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7569b2d21e72d8d827a21c0b35779baa
https://hdl.handle.net/10400.4/327

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání